References
- Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006;55:1048–1065.
- Rendon M, Berneburg M, Arellano I, Picardo M. Treatment of melasma. J Am Acad Dermatol. 2006;54:S272–281.
- Jeong SY, Shin JB, Yeo UC, Kim WS, Kim IH. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre-or post-treatment triple combination cream. Dermatol Surg. 2010;36:909–918.
- Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg. 2010;36:76–87.
- Haddad AL, Matos LF, Brunstein F, Ferreira LM, Silva A, Costa D, Jr. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma. Int J Dermatol. 2003;42:153–156.
- Wang CC, Hui CY, Sue YM, Wong WR, Hong HS. Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol Surg. 2004;30:1196–1200.
- Negishi K, Kushikata N, Tezuka Y, Takeuchi K, Miyamoto E, Wakamatsu S. Study of the incidence and nature of “very subtle epidermal melasma” in relation to intense pulsed light treatment. Dermatol Surg. 2004;30:881–886; discussion 886.
- Polnikorn N. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports. J Cosmet Laser Ther. 2008;10:167–173.
- Choi M, Choi JW, Lee SY, Choi SY, Park HJ, Park KC, Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma. J Dermatolog Treat. 2010;21:224–228.
- Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. Lasers Surg Med. 2010;42:712–19.
- Kim MJ, Kim JS, Cho SB. Punctate leucoderma after melasma treatment using 1064-nm Q-switched Nd:YAG laser with low pulse energy. J Eur Acad Dermatol Venereol. 2009;23:960–962.
- Kang WH, Chun SC, Lee S. Intermittent therapy for melasma in Asian patients with combined topical agents (retinoic acid, hydroquinone and hydrocortisone): clinical and histolotical studies. J Dermatol. 1998;25:587–596.
- Jeong SY, Bak H, Choi JH, Kim IH. New melasma treatment by collimated low fluence Q-switched Nd:YAG laser. Kor J Dermatol. 2008;46:1163–1170.
- Kim JH, Kim H, Park HC, Kim IH. Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation. J Invest Dermatol. 2010;130:2333–2335.
- Kang WH, Yoon KH, Lee ES, Kim J, Lee KB, Yim H, Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146:228–237.
- Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46:111–116.
- Li YH, Chen JZ, Wei HC, Wu Y, Liu M, Xu YY, Efficacy and safety of intense pulsed light in treatment of melasma in Chinese patients. Dermatol Surg. 2008;34:693–700; discussion 700–691.
- Yamashita T, Negishi K, Hariya T, Kunizawa N, Ikuta K, Yanai M, Intense pulsed light therapy for superficial pigmented lesions evaluated by reflectance-mode confocal microscopy and optical coherence tomography. J Invest Dermatol. 2006;126:2281–2286.